Immune-mediated processes in neurodegeneration: where do we stand? Marc Fakhoury Review 12 February 2016 Pages: 1683 - 1701
Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue Laura NastasiGiovanni MostileSantiago Catania Original Communication 08 June 2016 Pages: 1702 - 1708
Serial electrophysiological findings in Guillain–Barré syndrome not fulfilling AIDP or AMAN criteria Takafumi HosokawaHideto NakajimaToshiaki Hanafusa Original Communication 08 June 2016 Pages: 1709 - 1718
Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases Hisanori KinoshitaHodaka YamakadoRyosuke Takahashi Original Communication 10 June 2016 Pages: 1719 - 1726
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study Pietro AnnovazziM. CapobiancoA. Ghezzi Original Communication 10 June 2016 Pages: 1727 - 1735
Re-review of MRI with post-processing in nonlesional patients in whom epilepsy surgery has failed Z. Irene WangP. SuwanpakdeeA. V. Alexopoulos Original Communication 13 June 2016 Pages: 1736 - 1745
EEG ultradian rhythmicity differences in disorders of consciousness during wakefulness Andrea PiarulliMassimo BergamascoSteven Laureys Original Communication 13 June 2016 Pages: 1746 - 1760
Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy? Pierre LozeronVincent RibragNathalie Kubis Original Communication 17 June 2016 Pages: 1761 - 1770
Transient monocular blindness and the risk of vascular complications according to subtype: a prospective cohort study Eline J. VolkersRichard C. J. M. DondersL. Jaap Kappelle Original Communication Open access 17 June 2016 Pages: 1771 - 1777
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis Scott D. NewsomeBernd C. KieseierGuido Sabatella Original Communication Open access 17 June 2016 Pages: 1778 - 1787
Pathological laughing and crying in amyotrophic lateral sclerosis is related to frontal cortex function Annemarie HübersJan KassubekAlbert C. Ludolph Original Communication 17 June 2016 Pages: 1788 - 1795
Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis Alon KalronUri Givon Original Communication 17 June 2016 Pages: 1796 - 1801
Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study Emanuele D’AmicoCarmela LeoneFrancesco Patti Original Communication 17 June 2016 Pages: 1802 - 1809
Variables associated with upper extremity function in patients with Duchenne muscular dystrophy Mariska M. H. P. JanssenJan C. M. HendriksImelda J. M. de Groot Original Communication Open access 17 June 2016 Pages: 1810 - 1818
Subjective body vertical: a promising diagnostic tool in idiopathic normal pressure hydrocephalus? C. SelgeF. SchoeberlK. Jahn Original Communication 22 June 2016 Pages: 1819 - 1827
Altered striatal circuits underlie characteristic personality traits in Parkinson’s disease Toru IshiiNobukatsu SawamotoHidenao Fukuyama Original Communication 22 June 2016 Pages: 1828 - 1839
Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study Rohit ShankarMatthew WalkerCraig Newman Original Communication 22 June 2016 Pages: 1840 - 1846
CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt–Jakob disease suspected cases with inconclusive 14-3-3 result M. J. LeitãoI. BaldeirasC. R. Oliveira Original Communication 29 June 2016 Pages: 1847 - 1861
Be aware of Wolfram syndrome when examining ataxic patients Antonella AntenoraMaria LietoAlessandro Filla Letter to the Editors 17 June 2016 Pages: 1862 - 1863
CSF1R-related leukoencephalopathy mimicking primary progressive multiple sclerosis Carol Prieto-MorinXavier AyrignacPierre Labauge Letter to the Editors 17 June 2016 Pages: 1864 - 1865
Progressive multifocal leukoencephalopathy in a patient with silicosis Alexandre BonnetAnne KerbratJacques Gasnault Letter to the Editors 14 July 2016 Pages: 1866 - 1868
Extensive and severe CNS demyelination associated with golimumab therapy Elisabeth MaillartCaroline PapeixCéline Louapre Letter to the Editors 25 July 2016 Pages: 1869 - 1871
Charles Bonnet syndrome successfully treated with levetiracetam Thomas GrüterIlya AyzenbergChristian Börnke Letter to the Editors 02 August 2016 Pages: 1872 - 1875
Extensive bilateral striopallidodentate calcinosis: a 50 years history of hypoparathyroidism presenting like a parkinsonian syndrome G. DonzusoG. SciaccaM. Zappia Letter to the Editors 02 August 2016 Pages: 1876 - 1879
Some recent advances in multiple sclerosis Claire McCarthyJohn Thorpe Neurological Update 25 April 2016 Pages: 1880 - 1886
The consequences of valproate exposure in utero Rhys H. ThomasNeil P. Robertson Journal club Open access 26 August 2016 Pages: 1887 - 1889
Vladimir K. Roth (1848–1916) Yury V. GavrilovAnna A. VorobyevaPhilipp O. Valko Pioneers in Neurology 12 February 2016 Pages: 1890 - 1892